SAN DIEGO–(BUSINESS WIRE)–April 28, 2022–
DexCom, Inc. has updated its first quarter 2022 earnings call due to technical difficulties with the conference call provider. The conference call will now begin at 5:30 p.m. (Eastern time). The link to the webcast will be available on DexCom, Inc.’s Investor Relations website at investor.dexcom.com and will be archived there for future reference.
To listen to the conference call, please dial (866) 374-5140 (US/Canada) or (404) 400-0571 (International) and use the confirmation number “41691074#” approximately five minutes before the time. of start.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative Continuous Glucose Monitoring (CGM) systems. Based in San Diego, California, and with operations across Europe, Dexcom has established itself as a leader in diabetes care technology. By listening to the needs of users, caregivers and providers, Dexcom simplifies and improves diabetes management worldwide. For more information about Dexcom CGM, visit www.dexcom.com.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20220428006330/en/
CONTACT: Media Contact
James McIntosh
619-884-2118
[email protected] Contact
Sean Christensen
858-203-6657
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: DIABETES HEALTH MEDICAL DEVICES
SOURCE: DexCom, Inc.
Copyright BusinessWire 2022.
PUBLISHED: 04/28/2022 17:27 / DISK: 04/28/2022 17:27
http://www.businesswire.com/news/home/20220428006330/en
